We are live on ! Find out more
HL

Harding Loevner Portfolio holdings

AUM $10.6B
1-Year Est. Return 19.39%
This Fund
S&P 500
This Quarter Est. Return
+9.85%
1 Year Est. Return
+19.39%
3 Year Est. Return
+79.14%
5 Year Est. Return
+100.61%
10 Year Est. Return
+428.16%
AUM
$27.7B
AUM Growth
+$6.83B
Cap. Flow
+$4.52B
Cap. Flow %
16.29%
Top 10 Hldgs %
32.19%
Holding
190
New
40
Increased
41
Reduced
54
Closed
12
Avg Time Held
11.1 quarters
Top 10 Avg Time Held
7.1 quarters
Top 20 Avg Time Held
9.8 quarters

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$803M
2
TSM icon
TSMC
TSM
+$458M
3
NBIS
Nebius Group N.V.
NBIS
+$373M
4
TTD icon
Trade Desk
TTD
+$276M
5
NTES icon
NetEase
NTES
+$159M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Miscellaneous 19.78%
3 Financials 17.49%
4 Communication Services 9.19%
5 Consumer Discretionary 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BWA icon
101
BorgWarner
BWA
$12.5B
$62K ﹤0.01%
1,832
+581
+46% +$20K
2018 Q1
10 quarters
JPM icon
102
JPMorgan Chase
JPM
$885B
$62K ﹤0.01%
641
– –
2017 Q2
13 quarters
MRK icon
103
Merck
MRK
$359B
$61K ﹤0.01%
769
– –
2018 Q4
7 quarters
ADP icon
104
Automatic Data Processing
ADP
$107B
$58K ﹤0.01%
418
– –
2017 Q4
11 quarters
DPZ icon
105
Domino's
DPZ
$10.2B
$58K ﹤0.01%
137
– –
2020 Q1
2 quarters
IT icon
106
Gartner
IT
$12.1B
$58K ﹤0.01%
+461
New +$58.6K
2020 Q3
0 quarters
CGNX icon
107
Cognex
CGNX
$10.6B
$57K ﹤0.01%
876
– –
2018 Q2
9 quarters
SBNY
108
DELISTED
Signature Bank
SBNY
$56K ﹤0.01%
671
– –
2016 Q1
18 quarters
NBIX icon
109
Neurocrine Biosciences
NBIX
$14.5B
$54K ﹤0.01%
562
+306
+120% +$35.4K
2020 Q1
2 quarters
ROL icon
110
Rollins
ROL
$15.4B
$53K ﹤0.01%
1,457
– –
2017 Q2
13 quarters
SBUX icon
111
Starbucks
SBUX
$103B
$50K ﹤0.01%
+578
New +$46.1K
2020 Q3
0 quarters
ADBE icon
112
Adobe
ADBE
$94.3B
$44K ﹤0.01%
90
– –
2017 Q2
13 quarters
EMR icon
113
Emerson Electric
EMR
$90.3B
$44K ﹤0.01%
666
– –
2018 Q1
10 quarters
HEI icon
114
HEICO Corp
HEI
$41.7B
$44K ﹤0.01%
419
– –
2018 Q1
10 quarters
ZTS icon
115
Zoetis
ZTS
$30.9B
$43K ﹤0.01%
261
– –
2017 Q2
13 quarters
ENS icon
116
EnerSys
ENS
$6.48B
$41K ﹤0.01%
606
– –
2018 Q1
10 quarters
UNH icon
117
UnitedHealth
UNH
$340B
$41K ﹤0.01%
133
-13,529
-99% -$4.16M
2019 Q1
6 quarters
RGA icon
118
Reinsurance Group of America
RGA
$16.7B
$40K ﹤0.01%
415
– –
2017 Q2
13 quarters
ALTR
119
DELISTED
Altair Engineering Inc
ALTR
$40K ﹤0.01%
942
– –
2019 Q3
4 quarters
IPGP icon
120
IPG Photonics
IPGP
$3.33B
$34K ﹤0.01%
202
+95
+89% +$15.7K
2014 Q2
25 quarters
CSCO icon
121
Cisco
CSCO
$467B
$33K ﹤0.01%
845
– –
2017 Q2
13 quarters
GWRE icon
122
Guidewire Software
GWRE
$13.7B
$32K ﹤0.01%
308
– –
2018 Q2
9 quarters
ABBV icon
123
AbbVie
ABBV
$489B
$29K ﹤0.01%
332
+180
+118% +$16.9K
2020 Q1
2 quarters
HCSG icon
124
Healthcare Services Group
HCSG
$1.41B
$28K ﹤0.01%
1,304
– –
2017 Q3
12 quarters
IDXX icon
125
Idexx Laboratories
IDXX
$40.8B
$28K ﹤0.01%
70
– –
2017 Q2
13 quarters

Similar funds

Harding Loevner's Q3 2020 Portfolio in Review

As of Q3 2020, Harding Loevner held 190 positions worth $27.7B, up 33% from $20.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Harding Loevner deployed $4.52B of net new capital in Q3 2020, opening 40 new positions and adding to 41 existing holdings. Its largest new stake was INFINEON TECH AG ADS(REP1 ORD): 13,249,533 shares worth $374M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Financials.

On the sell side, the largest reduction was Alibaba, an estimated $803M trimmed.

  • Harding Loevner's largest Q3 2020 buy was INFINEON TECH AG ADS(REP1 ORD): 13,249,533 shares worth $374M.
  • Harding Loevner added most to Illumina in Q3 2020, an estimated $114M increase.
  • Harding Loevner's biggest Q3 2020 reduction was Alibaba, cutting an estimated $803M.
  • Harding Loevner fully exited iShares MSCI ACWI ex US ETF in Q3 2020, selling an estimated $2.21M.
  • Harding Loevner's ten largest holdings make up 32% of its $27.7B portfolio in Q3 2020.
  • Harding Loevner opened 40 new positions and closed 12 in Q3 2020.
  • Harding Loevner's portfolio value rose 33% quarter-over-quarter to $27.7B.

Based on Harding Loevner's 13F filing for Q3 2020, filed 16 Nov 2020.